Chularat Hospital PCL (BKK:CHG-R) YoY EBITDA Growth: 5.41% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:CHG-R Chularat Hospital PCL BKK:CHG-R
81 GF Score
Price ฿1.56
GF Value ฿1.97
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Chularat Hospital PCL YoY EBITDA Growth?

Chularat Hospital PCL BKK:CHG-R 81 YoY EBITDA Growth is 5.41% as of Jun. 2026. GuruFocus rates BKK:CHG-R with a GF Score™ of 81/100 and a GF Value™ of ฿1.97 (Modestly Undervalued). The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chularat Hospital PCL's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 5.41%.

Chularat Hospital PCL's EBITDA per Share for the three months ended in Jun. 2026 was ฿0.04.

Chularat Hospital PCL YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Chularat Hospital PCL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chularat Hospital PCL YoY EBITDA Growth Chart

Chularat Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 286.47 -30.16 -54.04 -1.82 -1.23

Chularat Hospital PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.71 -27.87 73.91 5.13 5.41
BKK:CHG-R
81GF Score
Chularat Hospital PCL BKK:CHG-R
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chularat Hospital PCL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chularat Hospital PCL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.16-0.162)/ | 0.162 |
=-1.23 %

Chularat Hospital PCL's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.039-0.037)/ | 0.037 |
=5.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 5.41% mean?
Chularat Hospital PCL (BKK:CHG-R) has a YoY EBITDA Growth of 5.41% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chularat Hospital PCL and its competitors.
Is Chularat Hospital PCL's YoY EBITDA Growth too high?
Chularat Hospital PCL's current YoY EBITDA Growth is 5.41%. Overall, Chularat Hospital PCL has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chularat Hospital PCL's YoY EBITDA Growth compare to HCA and THC?
Chularat Hospital PCL's YoY EBITDA Growth of 5.41% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chularat Hospital PCL and its competitors. Chularat Hospital PCL's current YoY EBITDA Growth is 5.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chularat Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Chularat Hospital PCL (BKK:CHG-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.97, compared to a current price of ฿1.56 — trading 20.8% below its estimated fair value. The current YoY EBITDA Growth is 5.41%. Chularat Hospital PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Chularat Hospital PCL (BKK:CHG-R), the current YoY EBITDA Growth is 5.41% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chularat Hospital PCL (BKK:CHG-R) Overvalued in 2026?

Based on GuruFocus' analysis, Chularat Hospital PCL stock appears to be undervalued. The current stock price of ฿1.56 is trading 20.8% below its estimated GF Value™ of ฿1.97. GuruFocus considers Chularat Hospital PCL to be Modestly Undervalued.

Key valuation signals for BKK:CHG-R:

  • YoY EBITDA Growth: 5.41%
  • GF Value™: ฿1.97 vs. price of ฿1.56 (20.8% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the BKK:CHG-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chularat Hospital PCL Business Description

Other Exchanges CHG:Thailand
Address 88/8-9, Teparak Km. 15 Road, Tambol Bangpla, Amphur Bangplee, Samut Prakarn, THA, 10540
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. The Group operates a private hospital business which is one business segment. It has only one geographical segment as the business operates only in Thailand.
81GF Score

Get the complete analysis for BKK:CHG-R

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.56
Price
฿1.97
GF Value